This announcement follows the earlier supperannuation of Tummala Venkata Rao, Vice President - Production of the Company, further indicating shifts within Natco Pharma’s executive team. In March, the ...

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development manufacturing and marketing of Finished Dosage Formulations (FDF) and Active ...

Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 14,270.58 Crore) operating in Pharmaceuticals sector. Natco Pharma Ltd. key Products/Revenue Segments ...

Natco Pharma Ltd. is a Public Limited Listed company incorporated on 19/09/1981 and has its registered office in the State of Telangana, India. Company's Corporate Identification Number(CIN) is ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company that specialises in development, manufacturing and marketing of Finished Dosage Formulations (FDF ...

Cash Taxes Paid 286.30 177.50 48.20 130.00 ...

Natco Pharma has announced the supperannuation of Tummala Venkata Rao, Vice President - Production of the Company. "With effect from the closure of business hours on 31st March, 2025, Mr. Tummala ...

Natco Pharma CEO Aurobindo Pharma, Dr. Reddy’s Laboratories, Sun Pharma, Lupin, Cipla, Natco Pharma, Gland Pharma were among the shares on the upswing. All the 20 entities part of the Nifty ...

Laurus Labs slumped 11.6%, Aurobindo declined 2%, Cipla fell 1.1% and Strides dropped 5%. Other pharma shares also declined with 19 out of 20 stocks on the Nifty Pharma index ending lower. The pharma ...

Disclosure under regulation 30 of the SEBI (LODR) Regulations, 2015 ...